- Home
- RBBN vs REPL Comparison
RBBN vs REPL Comparison
Compare RBBN & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBBN
- REPL
- Stock Information
- Founded
- RBBN 1997
- REPL 2015
- Country
- RBBN United States
- REPL United States
- Employees
- RBBN N/A
- REPL N/A
- Industry
- RBBN EDP Services
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- RBBN Technology
- REPL Health Care
- Exchange
- RBBN Nasdaq
- REPL Nasdaq
- Market Cap
- RBBN 901.5M
- REPL 851.0M
- IPO Year
- RBBN 2000
- REPL 2018
- Fundamental
- Price
- RBBN $3.84
- REPL $8.40
- Analyst Decision
- RBBN Strong Buy
- REPL Strong Buy
- Analyst Count
- RBBN 4
- REPL 6
- Target Price
- RBBN $6.00
- REPL $20.00
- AVG Volume (30 Days)
- RBBN 469.6K
- REPL 717.2K
- Earning Date
- RBBN 04-23-2025
- REPL 05-15-2025
- Dividend Yield
- RBBN N/A
- REPL N/A
- EPS Growth
- RBBN N/A
- REPL N/A
- EPS
- RBBN N/A
- REPL N/A
- Revenue
- RBBN $833,881,000.00
- REPL N/A
- Revenue This Year
- RBBN $7.75
- REPL $31.16
- Revenue Next Year
- RBBN $5.27
- REPL N/A
- P/E Ratio
- RBBN N/A
- REPL N/A
- Revenue Growth
- RBBN 0.91
- REPL N/A
- 52 Week Low
- RBBN $2.47
- REPL $4.92
- 52 Week High
- RBBN $5.38
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- RBBN 39.44
- REPL 21.08
- Support Level
- RBBN $3.96
- REPL $10.17
- Resistance Level
- RBBN $4.08
- REPL $10.78
- Average True Range (ATR)
- RBBN 0.14
- REPL 0.65
- MACD
- RBBN -0.01
- REPL -0.21
- Stochastic Oscillator
- RBBN 12.96
- REPL 0.93
About RBBN Ribbon Communications Inc.
Ribbon Communications Inc provides network solutions to service providers and enterprises. It enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. It has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.